Reimbursement expansion plans in Russia could offset 'protectionist' policies
This article was originally published in Scrip
Executive Summary
The Russian government is considering an increasingly protectionist approach to drug reimbursement. Plans have been announced recently to prevent foreign companies' participation in public drug programs if at least two domesticallyproduced alternatives of a molecule are available.